10/10/2022 12:24:53 PM - Rebounding above its 50 DMA line ($88) with today&#39;s gap up gain. Earnings improved +43% on +28% sales revenues in the Jun &#39;22 quarter versus the year ago period, its 4th quarterly comparison above the +25% minimum earnings guideline (C criteria). Fundamental concerns remain after a downturn in in FY &#39;20 earnings (A criteria).<br><hr>6/17/2022 12:57:35 PM - Retreated from new all-time highs in May and slumped below its 50 DMA line ($88.55). Earnings improved +84% on +50% sales revenues in the Mar &#39;22 quarter versus the year ago period, its 4th quarterly comparison above the +25% minimum earnings guideline (C criteria). Fundamental concerns remain after a downturn in in FY &#39;20 earnings (A criteria).<br><hr>5/11/2022 12:40:57 PM - Challenging its all-time high with today&#39;s gain. Earnings improved +84% on +50% sales revenues in the Mar &#39;22 quarter versus the year ago period, its 4th quarterly comparison above the +25% minimum earnings guideline (C criteria). Fundamental concerns remain after a downturn in in FY &#39;20 earnings (A criteria).<br><hr>4/28/2022 12:52:10 PM - Earnings improved +84% on +50% sales revenues in the Mar &#39;22 quarter versus the year ago period, its 4th quarterly comparison above the +25% minimum earnings guideline (C criteria). Fundamental concerns remain after a downturn in in FY &#39;20 earnings (A criteria).<br><hr>4/14/2022 12:41:22 PM - Earnings improved +84% on +24% sales revenues in the Dec &#39;21 quarter versus the year ago period, its 3rd quarterly comparison above the +25% minimum earnings guideline (C criteria). Fundamental concerns remain after a downturn in in FY &#39;20 earnings (A criteria).<br><hr>10/22/2019 12:41:26 PM - Testing its 200 DMA line with today&#39;s volume-driven loss. Earnings improved +23% on +12% sales revenues in the Jun &#39;19 quarterly comparison. Fundamental concerns remain.<br><hr>